BioImagene and Scimagix Merge to Provide Comprehensive Image Analysis and Informatics Solutions
BioImagene and Scimagix are pleased to announce their merger. The combination of BioImagene’s core competency in image analysis with Scimagix’ image management and data mining technology address major pain-points in the discovery and diagnostics markets. Together, they will provide complete, integrated solutions for gels, cells and tissues, from initial analysis to data mining and post-hoc analysis. This comprehensive, web-enabled suite of products is a major step toward the companies’ joint goal of enabling digital discovery and diagnostics.
“Scimagix provides a very good strategic fit with BioImagene. Together we have a critical mass of technology, products, customers and partners that positions us as a leading player in the marketplace,” said Mohan Uttarwar, President and CEO of BioImagene, and of the combined company going forward.
“This is a major step toward the fulfillment of image informatics’ promise of advancing science, technology and healthcare. BioImagene and Scimagix together will extend and amplify these benefits. The combined offerings will be very valuable to our customers. They will facilitate a seamless workflow resulting in higher through-put and higher productivity, translating into improved discovery and diagnostic processes and outcomes,” said Robert Dunkle, President of Scimagix.
And customers of both BioImagene and Scimagix agree. “I’m very encouraged about the merging of these technology platforms,” said Bruce Keyt, VP of Preclinical Development at Abgenix, and a customer of both companies. “It relieves me of concerns regarding reinventing the wheel. We won’t have to worry about integration challenges when we use Scimagix’ storage and data mining tools for the data we get from BioImagene’s quantitation and analysis. This will broaden our information transfer technology. We’ve worked a great deal with both Scimagix and BioImagene. These technologies working together will provide very powerful tools for evaluating therapeutic antibodies at Abgenix.”
The combined company will provide all existing customers with ongoing support, maintenance and further development of both companies’ product lines.
About BioImagene
BioImagene provides sophisticated bio-image analysis products built on iHarness, its patent-pending technology platform. BioImagene’s products allow physicians and researchers to analyze and interpret images with far greater speed and consistency. The data management systems of BioImagene’s technology facilitate communication and collaboration, improving the standard of patient care and increasing the speed of discovery. Its scalable digital image analysis solutions have been embraced by clinicians, industry and researchers alike.
BioImagene is headquartered in San Jose, California. For more information on BioImagene, visit the company’s web site at www.bioimagene.com .
About Scimagix
Scimagix(R) Inc., based in San Mateo, Calif., is the leading provider of image informatics solutions for pharmaceutical research and development (R&D). Its flagship SIMS(R) (Scientific Image Management System) platform, an Oracle(R)/Web-based database management system, utilizes open architecture to deliver a comprehensive and searchable image database. Image informatics technology integrates valuable image and non-image data into SIMS, allowing scientists to search, mine and analyze all results. ProteinMine(TM), running on top of SIMS, supports high throughput analysis and mining of image data with proprietary visual content search technology, dramatically increasing the accuracy and productivity of R&D processes. Scimagix serves most of the top 15 pharmaceutical companies including Pfizer Global R&D, Hoffmann La Roche and Eli Lilly & Co. For more information about Scimagix, please visit www.scimagix.com/ .
